Boehringer Ingelheim (1) 썸네일형 리스트형 Boehringer Ingelheim receives approval for SENVELGO® in Europe the first oral liquid medication for diabetic cats Up to one in three cats are euthanized within the first year of diagnosis due to previous complex treatments Boehringer Ingelheim, a global leader in animal health, has received marketing authorization from the European Commission for SENVELGO® (active ingredient: velagliflozin), marking a significant step for the treatment of feline diabetes in.. 이전 1 다음
